Molecular Genetics of Heterotaxy and Related Congenital Heart Defects
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorIndiana University
About this trial
The goal of this study is to obtain specimens and data from individuals and their families with heterotaxy and related congenital heart defects in order to clarify the molecular genetics of this disorder. The knowledge gained from the analysis of this information will provide the basis for future genetic counseling as well as contribute to knowledge about the biology of normal and abnormal development of left-right anatomic asymmetry.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Subjects with heterotaxy and related congenital heart defects
Family members of subjects with heterotaxy and related congenital heart defects
Disqualifiers
Subjects without heterotaxy and related congenital heart defects
Family members of subjects without heterotaxy and related congenital heart defects
Trial population
children affected with heterotaxy syndrome and/or congenital heart defects and their relatives
Trial design
Design model
Family-based
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
2,000 Participants
are grouped into 1 trial groupGroup A: Heterotaxy and congenital heart defects
Trial outcomes
Primary outcomes
1
Clarify Molecular Genetics of Heterotaxy and Related Congenital Heart Defects
These results will provide important information on the causes, management, and prognosis of heterotaxy and related congenital heart defects. This will provide the basis for future genetic testing and genetic counseling as well as contribute to knowledge about the biology of normal and abnormal development of left-right asymmetry.
Time frame
8 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov